I see everyone is excited about the upcoming June

I see everyone is excited about the upcoming June liver conference where topline Nash results for Leronlimab are slated to be discussed. It's undoubtably a good thing. But if I may shed a little light on what looks to be happening at the conference, I think it could strengthen my theory that we won't have to wait until then to get the topline report.

I've attended many medical conferences in my time as a combination medical sales rep/Adonis, and they're all structured similarly. Learn about the conference's topics at your choice of sessions, earning continuing education credits along the way. Many courses overlap, causing the attendees to choose which ones to miss and which ones to attend. A lot of the attendees have very specific reasons for going. It might be cancer, or Nash, or just to complete their continuing education requirements in a fun city amongst friends/colleagues. There are marquee events each day, set up in the main (best) conference room and given heavy focus by the organizers. Attendees will have much of their conference taken up by marquee events, as well as the singled out sessions or tracts they decide to focus on. And then there are the poster session, which is what Cytodyn’s “session” is listed as.

These poster sessions are usually a time in which they give students and researchers a chance to show off what they've been working on. It’s kind of like overflow for everything that deserves to be there but that there isn’t enough time or space to fit into the main program. And it's pretty much exactly what it sounds like, a session where there are a bunch of posters spread about, detailing studies or research conducted. One poster per topic, which needs to detail all the key points plus the conclusion. Those who did the work are usually standing there to explain the results and answer any questions. But the key here is that this is usually done at the end of a day, or during breaks. In other words, while it's always a part of conferences like this, it isn't always a focus. Like I said, it’s sort of an overflow thing.

And if you think about how boring a full day of back to back to back sessions are, if you're "lucky" enough to have ever had to go to a long conference, you'll know that when things aren't mandatory people tend to use those times for themselves. They go back to the room to drop a homecourt deuce, they call the family, they go find a bite to eat and refill the coffee. Statistically, some of them will masturbate. It’s science.

This isn't to say that this poster session won't have plenty of people wandering by to hear or see the results. It just means that in the grand scheme of conference related things, it's not going to be a priority or even a built-in part of the standard attendee itinerary. And for that reason, I can't imagine that Cytodyn's brain trust thinks that would be a good way to debut the topline 700mg Nash data to the world.

Which means by the time the conference comes around they'll have already announced it. Hell, maybe even this morning. Though I arbitrarily picked May 24th as the day it’ll come because fool me once, shame on you. Fool me twice, shame on me. Fool me 42 times? Now I pick random dates and don’t believe anything until I see it. I ain’t nobody’s fool!

Which made me think of the song lyrics “just a fool to believe…she’s like the wind”, so I googled it to be sure I had the lyrics correct in case I wanted to make a joke about it. Now I’m today years old just learning that Patrick Swayze sung the damn thing. I have no joke now. Too stunned.

Anyway, look out for topline results before the June conference. I’d bet the life of today’s greatest living actor/singer, Patrick Swayze, on it.